# ALPHAMEMORY, LLC: Phase I STTR: Targeting substrate of gamma-secretase for selective amyloid reduction in Alzheimer’s Disease

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | ALPHAMEMORY, LLC |
| Location | LATHAM, NY |
| Project | Phase I STTR: Targeting substrate of gamma-secretase for selective amyloid reduction in Alzheimer’s Disease |
| Project number | 5R41AG092199-02 |
| Mechanism | R41 |
| Institute | National Institute on Aging |
| Award | $247,779 |
| Awarded | 2026-08-28 |
| Project period | 2025-09-20 to 2027-09-19 |
| UEI | ZHQPTDKH45Y1 |

## Why this score
- Award of $247,779.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11419572). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.